Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease with Clinically Significant Fibrosis in Obese Patients with Type 2 Diabetes Mellitus — China, 2017–2024

  • loading
  • Yuping Chen, Xiao Liang, Yuxia Qi, Chuan Liu, Bingtian Dong, Xia Li, Jie Shen, Xiqiao Zhou, Xuan Liang, Minghua Zheng, Huating Li, Vincent Wai-Sun Wong, Zobair M Younossi, Yuemin Nan, Xiaolong Qi. Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease with Clinically Significant Fibrosis in Obese Patients with Type 2 Diabetes Mellitus — China, 2017–2024J. China CDC Weekly, 2025, 7(47): 1483-1490. DOI: 10.46234/ccdcw2025.248
    Citation: Yuping Chen, Xiao Liang, Yuxia Qi, Chuan Liu, Bingtian Dong, Xia Li, Jie Shen, Xiqiao Zhou, Xuan Liang, Minghua Zheng, Huating Li, Vincent Wai-Sun Wong, Zobair M Younossi, Yuemin Nan, Xiaolong Qi. Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease with Clinically Significant Fibrosis in Obese Patients with Type 2 Diabetes Mellitus — China, 2017–2024J. China CDC Weekly, 2025, 7(47): 1483-1490. DOI: 10.46234/ccdcw2025.248

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return